Theravance Biopharma Inc at Morgan Stanley Healthcare Conference Transcript

Sep 09, 2019 / 03:05PM GMT
Jeff Hung - Morgan Stanley, Research Division - Equity Analyst

Welcome to the healthcare conference. I'm Jeff Hung one of the biotech analysts. Before we start, please note that all important disclosures including personal holdings disclosures and Morgan Stanley disclosures appear on the Morgan Stanley public website at www.morganstanley.com/research disclosures, or at the registration desk. For this session, we have from Theravance Biopharma, Rick Winningham, CEO; Andrew Hindman, CFO; and Brett Haumann, CMO. Welcome.

Rick E. Winningham - Theravance Biopharma, Inc. - Chairman & CEO

Thank you. Thank you. Glad to be here.

Questions and Answers:

Jeff Hung - Morgan Stanley, Research Division - Equity Analyst

So as of this morning -- as this morning showed, the 12 to 16 months are going to be data-rich free-er companies, so we have a lot of ground to cover. But maybe first, for those who are in the room who are not as familiar with
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot